Historical Stock Price
ETFs Holding ABUS »    ABUS Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
02/14/2018 $5.50 $5.90 $5.36 $5.90 385.30K
02/15/2018 $5.90 $5.95 $5.60 $5.75 336.30K
02/16/2018 $5.70 $5.70 $5.55 $5.65 101.90K
02/20/2018 $5.60 $5.65 $5.35 $5.50 177.20K
02/21/2018 $5.50 $5.60 $5.20 $5.25 116.20K
Arbutus Biopharma is a therapeutic solutions company focused on discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus (HBV) infection. Co.'s HBV pipeline consists of multiple drug candidates, with differing and complementary mechanisms of action. The candidates include: RNAi 1.0 (ARB-1467), which is Co.'s main RNA Interference (RNAi) HBV candidate designed to eliminate HBV surface antigen expression in patients chronically infected with HBV; RNAi 2.0 (ARB-1740), Co.'s follow-on RNAi HBV candidate; and Core Protein/ Capsid Assembly Inhibitors (AB-423), which is being developed as oral therapeutics for the treatment of chronic HBV infection.
ABUS historical stock prices picture
Arbutus Biopharma (ABUS) has the following price history information. Looking back at ABUS historical stock prices for the last five trading days, on February 14, 2018, ABUS opened at $5.50, traded as high as $5.90 and as low as $5.36, and closed at $5.90. Trading volume was a total of 385.30K shares. On February 15, 2018, ABUS opened at $5.90, traded as high as $5.95 and as low as $5.60, and closed at $5.75. Trading volume was a total of 336.30K shares. On February 16, 2018, ABUS opened at $5.70, traded as high as $5.70 and as low as $5.55, and closed at $5.65. Trading volume was a total of 101.90K shares. On February 20, 2018, ABUS opened at $5.60, traded as high as $5.65 and as low as $5.35, and closed at $5.50. Trading volume was a total of 177.20K shares. On February 21, 2018, ABUS opened at $5.50, traded as high as $5.60 and as low as $5.20, and closed at $5.25. Trading volume was a total of 116.20K shares.

ABUS Historical Stock Prices By Date:

ABUS historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Arbutus Biopharma shares, starting with a $10,000 purchase of ABUS, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 02/22/2008
End date: 02/21/2018
Start price/share: $4.60
End price/share: $5.25
Dividends collected/share: $0.00
Total return: 14.13%
Average Annual Total Return: 1.33%
Starting investment: $10,000.00
Ending investment: $11,413.32
Years: 10.01
Date Close
02/14/2018$5.90
02/15/2018$5.75
02/16/2018$5.65
02/20/2018$5.50
02/21/2018$5.25

ABUS Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2018, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.